Abstract
Trifarotene (Aklief) is a topical retinoid labeled for the treatment of facial and truncal acne vulgaris in patients nine years and older.1 Similar to other retinoids, its exact mechanism of action is not known, but it may work by normalizing keratinization and by having anti-inflammatory effects through stimulation of retinoic acid receptors.
| Original language | American English |
|---|---|
| Journal | American Family Physician |
| Volume | 102 |
| Issue number | 8 |
| State | Published - Oct 15 2020 |